Agrovax Naturals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 26-12-2024
- Paid Up Capital ₹ 1.11 M
as on 26-12-2024
- Company Age 3 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.90 M
as on 26-12-2024
- Revenue 9724.12%
(FY 2023)
- Profit 2523.18%
(FY 2023)
- Ebitda 3475.48%
(FY 2023)
- Net Worth 446.48%
(FY 2023)
- Total Assets 1583.04%
(FY 2023)
About Agrovax Naturals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.11 M.
The company currently has active open charges totaling ₹4.90 M.
Rajeev Sharma and Seema Devi serve as directors at the Company.
- CIN/LLPIN
U15100UP2021PTC156900
- Company No.
156900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Agrovax Naturals Private Limited offer?
Agrovax Naturals Private Limited offers a wide range of products and services, including Essential & Aromatic Oils, Menthol, Herb Oil, Fresh Flowers, Plants & Trees, Rose Flower, Natural Flowers, Dry Leaves.
Who are the key members and board of directors at Agrovax Naturals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Sharma  | Director | 15-Dec-2021 | Current |
| Seema Devi | Director | 15-Dec-2021 | Current |
Financial Performance of Agrovax Naturals.
Agrovax Naturals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 9724.12% increase. The company also saw a substantial improvement in profitability, with a 2523.18% increase in profit. The company's net worth Soared by an impressive increase of 446.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrovax Naturals?
Unlock access to Agrovax Naturals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2023 | ₹4.00 M | Open |
State Bank Of India Creation Date: 17 Dec 2022 | ₹0.90 M | Open |
How Many Employees Work at Agrovax Naturals?
Agrovax Naturals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrovax Naturals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrovax Naturals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
